Dr. Albo joined the Augusta University team in August 2015. He currently serves as the Vice Chair in the Department of Surgery and the director of surgical services and co-leader of the colorectal cancer team at the Georgia Cancer Center. He serves as the surgeon-in-chief for Augusta University Health System.
Dr. Albo’s clinical expertise is on minimally invasive surgical oncology with emphasis on colorectal surgery. He has one of the highest utilization rates for laparoscopic surgery in patients with colon and rectal cancer in the US, resulting in significant outcomes advantages for patients, including less pain, faster and more complete recoveries, and lower rate of wound complications.
Areas of Expertise (8)
Media Appearances (3)
Medical College of Georgia names new surgery chairman
The Augusta Chronicle print
The Medical College of Georgia at Augusta University has named a new Department of Surgery chairman.
Dr. Daniel Albo, a surgical oncologist, educator and the current vice chairman of the department, will take over the chairman post July 1, according to a news release from the school.
Putting the puzzle pieces into place: How a surgical oncologist’s personal experience helped to revolutionize cancer care
Your Health Today - Augusta University online
Dr. Daniel Albo shares the story of his son, who died from brain cancer, and how being involved in his care played a part in his passion for helping every cancer patient he treats.
New administrative appointments at Georgia Cancer Center at Augusta University
Jagwire - Augusta University online
Dr. Daniel Albo has been named director of the Cancer Service Line for the Georgia Cancer Center.
Marshall CL1, Balentine CJ, Robinson CN, Wilks JA, Anaya D, Artinyan A, Awad SS, Berger DH, Albo D.
Our study suggests that although the recruitment of specialty-trained surgeons in a high volume center leads to improvement in surgical oncologic care, it is the establishment of a multidisciplinary center around the surgeons that leads to integrated care and improvements in oncologic outcomes.
Daniel Albo, MD, PhD.
Surgical site infections (SSIs), a vexing problem in colon surgery, increase morbidity and significantly increase the cost of care. In an elegant article in this issue of JAMA Surgery, Amri et al1 evaluate their patient population at a large tertiary care facility for patient and perioperative risk factors that may increase SSIs after colon cancer surgery.
Randi L.LassiterM.D.AsifTalukderM.D.Meryl M.AbramsB.S.Bao-LingAdamPh.D.DanielAlboM.D., Ph.D.Cassandra Q.WhiteM.D.
Several studies have demonstrated favorable outcomes for laparoscopic surgery over open surgery for the treatment of diverticular disease. This study was designed to analyze the relationship between race, socioeconomic status and the use of laparoscopy to address diverticulitis.